AQP1 and peripheral arterial disease: Our findings suggest AQP1 blockade or Aqp1 deletion as effective senotherapeutic strategy with potential of pro-angiogenic efficiency for recovery of ischemic vascular diseases such as coronary artery disease and peripheral arterial disease in older adults.